Liver fibrosis is closely linked with metabolic-associated diseases in patients with autoimmune hepatitis
Concurrent MADs, common in AIH patients, is an independent risk factor for severe fibrosis or inflammation; of note, combination with DM was also an independent predictor of severe liver fibrosis in AIH patients. While managing with AIH, routine assessment of co-existing MADs, especially DM, is also important.
Authors
- Kehui Liu (ORCID: https://orcid.org/0000-0001-8164-784X)
- Wanqing Chi
- Xiaoyin Wang (ORCID: https://orcid.org/0000-0002-6667-5209)
- Yezhou Ding (ORCID: https://orcid.org/0000-0001-6686-3317)
- Zhujun Cao (ORCID: https://orcid.org/0000-0002-8684-2107)
- Hui Wang (ORCID: https://orcid.org/0000-0002-5285-7917)
- Shisan Bao (ORCID: https://orcid.org/0000-0002-6687-3846)
- Mingyang Feng
- Ziqiang Li (ORCID: https://orcid.org/0000-0002-4954-1735)
- Gangde Zhao
- Lanyi Lin
Institutions
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
- Yale University (US)
Publication Details
- Journal
- Hepatology International
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1007/s12072-024-10727-w
- Citations
- 7
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- National Natural Science Foundation of China
- Ruijin Hospital